-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence
(2001) Views (409) Full article downloads
Authors: Craig S Patch, Linda C Tapsell, Peter G Williams, Michelle Gordon
Published Date January 2006
Volume 2006:2(2) Pages 157 - 162
DOI: http://dx.doi.org/10.2147/VHRM.S
Craig S Patch1, Linda C Tapsell1, Peter G Williams1, Michelle Gordon2
1National Centre of Excellence in Functional Foods, Northfields Avenue, University of Wollongong, New South Wales, Australia; 2Unilever Food and Health Research Institute, Rotterdam, The Netherlands
Abstract: Plant sterol-enriched foods are an effective dietary adjuvant in reducing cardiovascular risk by lowering total cholesterol and low density lipoprotein-cholesterol (LDLC) in serum by up to ~15%. The mechanism of action of plant sterols is different from those of 3-hydroxy-3-methylglutaryl coenzyme A inhibitors (statins) and thus their effect is additive. Combining plant sterols with other dietary components known to reduce cholesterol in a portfolio approach has proven to be most effective for reduction of hypercholesterolemia and provide an alternative treatment option for clinicians. Plant sterol-enriched foods provides clinicians with a relatively cheap, safe, and effective way to help patients manage their cardiovascular risk.
Keywords: plant sterols, plant stanols, cardiovascular risk, cholesterol, LDL-cholesterol
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




